Publication | Closed Access
Effects of Topical Janus Kinase Inhibition on Ocular Surface Inflammation and Immunity
35
Citations
24
References
2013
Year
Topical ophthalmic tofacitinib, a Janus kinase inhibitor, suppressed ocular surface inflammation and immunity in experimental corneal thermocautery and dry eye disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1